Pulmonary host defenses

Journal of Thoracic Imaging

Volumn 13, Issue 4, 1998, Pages 221-233

  Twigg III, Homer L ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cellular immune response; Host defense; Humoral immune response; Immunocompromised patient; Phagocytosis

Indexed keywords

ANTIBODY; ANTIGEN; ANTIOXIDANT; COMPLEMENT; PROTEINASE INHIBITOR;

ANTIBODY RESPONSE; CELLULAR IMMUNITY; CYTOTOXICITY; DEFENSE MECHANISM; GRANULOMATOSIS; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; INFLAMMATION; LOWER RESPIRATORY TRACT; LUNG; LUNG ALVEOLUS CELL; LUNG BIOPSY; LUNG DISEASE; LUNG INFECTION; PARTICULATE MATTER; PATHOGENESIS; PHAGOCYTE; REVIEW; TRACHEOBRONCHIAL TREE;

EID: 0031756769     PISSN: 08835993     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005382-199810000-00003     Document Type: Review

References (88)

1. Hofmann W, Koblinger L. Monte Carlo modeling of aerosol deposition in human lungs. Part III: comparison with experimental data. Journal of Aerosol Science 1992;23:51-63.
2. Brain JD, Valberg PA. Deposition of aerosol in the respiratory tract. American Review of Respiratory Disease 1979;120:1325-73.
3. Toremalm NG. The daily amount of tracheobronchial secretions in man. Acta Otolaryngol Suppl (Stockh) 1960;158:43-53.
4. Wong LB, Miller IF, Yeates DB. Regulation of ciliary beat frequency by autonomic mechanisms: in vitro. J Appl Physiol 1988; 65:1895-901.
5. Burman WJ, Martin WJ II. Oxidant-mediated ciliary dysfunction: possible role in airway disease. Chest 1986;89:410-3.
6. Wilson R, Cole PJ. The effect of bacterial products on ciliary function. American Review of Respiratory Disease 1988;138 (suppl):49-53.
7. Carson JL, Collier AM, Hu SS. Acquired ciliary defects in nasal epithelium of children with acute viral upper respiratory infections. N Engl J Med 1985;312:463-8.
8. Al-Bazzaz FJ, Cheng E. Effect of catecholamines on ion transport in dog tracheal epithelium. J Appl Physiol 1979;47:397-403.
9. Nathanson I, Widdicombe JH, Barnes PJ. Effect of vasoactive intestinal peptide on ion transport across dog tracheal epithelium. J Appl Physiol 1983;55:1844-8.
10. Girod S, Zahm JM, Plotkowski C, Beck G, Puchelle E. Role of the physiochemical properties of mucus in the protection of the respiratory epithelium. Eur Resp J 1992;5:477-87.
11. Puchelle E, Zahm JM, Girard F, Bertrand A, Polu JM, Aug F, Sadoul P. Mucociliary transport in vivo and in vitro. Relations to sputum properties in chronic bronchitis. European Journal of Respiralory Diseases 1980;61:254-64.
12. Cohen D, Arai SF, Brain JD. Smoking impairs long-term dust clearance from the lung. Science 1979;204:514-7.
13. Glasgow JE, Farrell BE, Fisher ES, Lauffenburger DA, Daniele RP. The motile response of alveolar macrophages. American Review of Respiratory Disease 1989;139:320-9.
14. Van Oss CJ. Phagocytosis: an overview. Methods in Enzymology 1986;132:3-15.
15. Wright JR, Youmas DC. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophages. Am J Physiol 1993;264(theme issue):L338-44.
16. Gordon S, Perry VH, Rabinowitz S, Chung LP, Rosen H. Plasma membrane receptors of the mononuclear phagocyte system. J Cell Sci 1988;9(suppl):1-26.
17. Tenner AJ, Robinson SL, Borchelt J, Wright JR. Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR- and CR1-mediated phagocytosis. J Biol Chem 1989;264:13923-8.
18. Schlesinger LS. The role of mononuclear phagocytes in tuberculosis. In: Lipscomb MF, Russell S, eds. Lung macrophages and dendritic cells in health and disease (lung biology in health and disease, Volume 102). New York: Marcel Dekker, Inc., 1997:437-80.
19. Aggeler J, Werb Z. Initial events during phagocytosis by macrophages viewed from outside and inside the cell: membrane-particle interactions and clathrin. J Cell Biol 1982;94:613-23.
20. Greenberg S, El Khoury J, di Virgilio F, Kaplan EM, Silverstein SC. Ca2+-independent F-actin assembly and disassembly during Fc receptor-mediated phagocytosis in mouse macrophages. J Cell Biol 1991;113:757-67.
21. Nathan CF. Secretion of oxygen intermediates: role in effector functions of activated macrophages. Federation Proceedings 1982; 41:2206-11.
22. Liew FY, Cox FEG. Nonspecific defense mechanism: the role of nitric oxide. Immunol Today 1991;12:A17-21.
23. Albina JE. On the expression of nitric oxide synthase by human macrophages. Why no NO. J Leukoc Biol 1995;58:643-9.
24. Adams D. Molecular interactions in macrophage activation. Immunol Today 1989;10:33-5.
25. Nathan DF, Prendergast TJ, Wiebe ME, et al. Activation of human macrophages. Comparison of other cytokines with interferon gamma. J Exp Med 1984;160:600-5.
26. Reynolds HY. Lung inflammation: role of endogenous chemotactic factors in attracting polymorphonuclear granulocytes. American Review of Respiratory Disease 1983;127:S16-25.
27. Senior RM, Girffin GL, Mecham RP. Chemotactic activity of elastin-derived peptides. J Clin Invest 1980;66:859-62.
28. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJ. Leukotriene B, a potent chemotactic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980; 286:264-5.
29. Strieter RM, Chensue SW, Basha MA, Standiford TJ, Lynch JP, Baggiolini M, Kunkel SL. Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-α, lipopolysaccharide, and interleukin-1β. Am J Respir Cell Mol Biol 1990;2: 321-6.
30. Standiford TJ, Kunkel SL, Liebler JM, Burdick MD, Gilbert AR, Stricter RM. Gene expression of macrophage inflammatory protein-1α from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. Am J Respir Cell Mol Biol 1993;9: 192-8.
31. Weiss SJ, Slivka A. Monocyte and granulocyte-mediated tumor cell destruction: a role for hydrogen peroxide-myeloperoxicase-chloride system. J Clin Invest 1982;69:255-62.
32. Gleich GJ, Frigos E, Loegering DA, Wassom DL, Steinmuller D. Cytotoxic properties of eosinophil major toxic protein. J Immunol 1979;123:2925-7.
33. Mills EL, Quie PG. Congenital disorders of the functions of polymorphonuclear leukocytes. Rev Infect Dis 1980;2:505-17.
34. Babior BM, Woodman RC. Chronic granulomatous disease. Semin Hematol 1990;27:247-59.
35. Gallin JI, Malech HL, Weening RS, Curnutte JT, Quie PG, Jaffe HS, Ezekowitz RAB. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991;324:509-16.
36. Root RK, Rosenthal AS, Balestra DJ. Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi syndrome leukocytes. J Clin Invest 1972;51:649-65.
37. Levitz S. Aspergillosis. Infect Dis Clin North Am 1989;3:1-18.
38. Gabrilove JL, Jakubowski A, Scher H, et al. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 1988;318:1414-22.
39. White CW, Repine JE. Pulmonary antioxidant defense mechanisms. Exp Lung Res 1985;8:81-96.
40. Tierney DF, Hacker AD. Polyamines, DNA synthesis, and tolerance to hyperoxia of mice and rats. American Review of Respiratory Disease 1989;139:387-92.
41. Janoff A. Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. American Review of Respiratory Disease 1985;132:417-33.
42. 1-antitrypsin augmentation therapy. Chest 1997;112: 872-4.
43. Tetley TD. Proteinase imbalance: its role in lung disease. Thorax 1993;48:560-5.
44. Sugimori T, Cooley J, Hoidal JR, Remold-O'Donnell E. Inhibitory properties of recombinant human monocyte/neutrophil elastase inhibitor. Am J Respir Cell Mol Biol 1995;13:314-22.
45. Rao NV, Marshall BC, Gray BH, Hoidal JR. Interaction of secretory leukocyte protease inhibitor with proteinase-3. Am J Respir Cell Mol Biol 1993;8:612-6.
46. Murphy G, Docherty AJP. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992;7:120-5.
47. Ross SC, Densen P. Complement deficiency states and infection: epidemiology, pathogenesis, and consequences of neisserial and other infections in an immune deficiency. Medicine 1984;63:243-73.
48. Johnson CA, Densen P, Wetsel RA, Cole FS, Goeken NE, Colten HR. Molecular heterogeneity of C2 deficiency. N Engl J Med 1992;326:871-4.
49. 3 deficiency. J Clin Invest 1976;57:222-9.
50. Wurzner R, Orren A, Lachmann PJ. Inherited deficiencies of the terminal components of human complement. Immunodeficiency Reviews 1992;3:123-47.
51. Unanue ER, Allen PM. The basis for the immunoregulatory role of macrophages and other accessory cells. Science 1987;236:551-7.
52. Saltini C, Kirby M, Trapnell BC, Tamura N, Crystal RG. Biased accumulation of T lymphocytes with "memory" -type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J Exp Med 1990;170:1123-40.
53. Toews GB, Vial WC, Dunn MM, Guzzetta P, Nunez G, Stastny P, Lipscomb MF. The accessory cell function of human alveolar macrophages in specific T cell proliferation. J Immunol 1984;132: 181-6.
54. Lipscomb MF, Lyons CR, Nunez G, et al. Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction. J Immunol 1986;136: 497-504.
55. Lem VM, Lipscomb MF, Weissler JC, Nunez G, Ball EJ, Stastny P, Toews GB. Bronchoalveolar cells from sarcoid patient demonstrate enhanced antigen presentation. J Immunol 1985;135:1766-71.
56. Weissler JC, Mendelson C, Moya F, Yarbrough WC JR. Effect of interstitial lung disease macrophages on T-cell signal transduction. Am J Respir Crit Care Med 1994;149:191-6.
57. Twigg HL, Lipscomb MF, Yoffe B, Barbaro D, Weissler JC. Enhanced accessory cell function by alveolar macrophages from patients infected with the human immunodeficiency virus: potential role for depletion of CD4+ T cells in the lung. Am J Respir Cell Mol Biol 1989;1:391-400.
58. Nicod LP, Lipscomb MF, Weissler JC, Lyons R, Albertson J, Toews GB. Mononuclear cells in human lung parenchyma: characterization of a potent accessory cell not obtained by bronchoavleolar lavage. American Review of Respiratory Disease 1987;136: 818-23.
59. Thomas R, Davis LS, Lipsky PE. Comparative accessory cell function of human peripheral blood dendritic cells and monocytes. J Immunol 1993;151:6840-52.
60. Koch F, Trockenbacher B, Kampgen E, et al. Antigen processing in populations of mature murine dendritic cells is caused by subsets of incompletely matured cells. J Immunol 1995;155:93-100.
61. Gong JL, McCarthy KM, Rogers RA, Schneeberger EE. Interstitial lung macrophages interact with dendritic cells to present antigenic peptides from particulate antigens to T cells. Immunology 1994; 81:343-51.
62. Kaltreider HB, Caldwell JL, Byrd PK. The capacity of normal murine alveolar macrophages to function as antigen-presenting cells for the initiation of primary antibody-forming cell responses to sheep erythrocytes in vitro. American Review of Respiratory Disease 1986;133:1097-104.
63. Kaltreider HB, Curtis JL, Arraj SM. The mechanism of appearance of specific antibody-forming cells in the lungs of inbred mice after immunization with sheep erythrocytes intratracheally. American Review of Respiratory Disease 1987;135:87-92.
64. Curtis JL, Kaltreider HB. Characterization of bronchoalveolar lymphocytes during a specific antibody-forming cell response in the lungs of mice. American Review of Respiratory Disease 1989;139: 393-400.
65. Curtis JL, Kim S, Scott PJ, Buechner-Maxwell VA. Adhesion receptor phenotypes of murine lung CD4+ T cells during the pulmonary immune response to sheep erythrocytes. Am J Respir Cell Mol Biol 1995;12:520-30.
66. Curtis JL, Byrd PK, Warnock ML, Kaltreider HB. Requirement of CD4+ T cells for cellular recruitment to the lungs of mice in response to a particulate intratracheal antigen. J Clin Invest 1991; 88:1244-54.
67. Beck JM, Warnock ML, Curtis JL, Sniezek MJ, Arraj-Peffer SM, Kaltreider HB, Shellito JE. Inflammatory responses to Pneumocystis carinii pneumonia in mice selectively depleted of helper T lymphocytes. Am J Respir Cell Mol Biol 1991;5:186-97.
68. Pober JS. Cytokines and endothelial cell biology. Physiol Rev 1990;70:427-51.
69. Stoolman LM. Adhesion molecules controlling lymphocyte migration. Cell 1989;56:907-10.
70. Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991;5: 171-7.
71. Murray HW. Interferon-γ, the activated macrophages and host defense against microbial challenge. Ann Intern Med 1988;108: 595-608.
72. Newman LS, Kreiss K, King TE Jr, Seay S, Campbell PA. Pathologic and immunologic alterations in early stages of beryllium disease: re-examination of disease definition and natural history. American Review of Respiratory Disease 1989;139:1479-86.
73. Boros DL. Mechanisms of granuloma formation in the lung. In: Daniele RP, ed. Immunology and immunologic diseases of the lung. Boston: Blackwell Scientific Publications. Inc., 1988:263-87.
74. Spits H, Borst J, Terhorst C, deVries JE. The role of T cell differentiation markers in antigen-specific and lectin-dependent cellular cytotoxicity mediated by T8+ and T4+ human cytotoxic T cell clones directed at class I and class II MHC antigens. J Immunol 1982;129:1563-9.
75. Robinson BWS, Pinkston P, Crystal RG. Natural killer cells are present in the normal human lung but are functionally impotent. J Clin Invest 1984;74:942-50.
76. Lawrence EC, Blease RM, Martin RR, Stevens PM. Immunoglobulin secreting cells in normal human bronchial lavage fluids. J Clin Invest 1978;62:832-5.
77. Rankin JA, Naegel GP, Schrader CE, Matthay RA, Reynolds HY. Air-space immunoglobulin production and levels in bronchoalveolar lavage fluid of normal subjects and patients with sarcoidosis. American Review of Respiratory Disease 1983;127:442-8.
78. The BAL Cooperative Group. Proteins in bronchoalveolar lavage fluid. American Review of Respiratory Disease 1990;141:5183-8.
79. Merrill WW, Naegel GP, Olchowski JJ, Reynolds HY. Immunoglobulin G subclass proteins in serum and lavage fluid of normal subjects. Quantitation and comparison with immunoglobulins A and E. American Review of Respiratory Disease 1985;131:584-7.
80. Rosen FS, Cooper MD, Wedgwood RJP. The primary immunodeficiencies. N Engl J Med 1984;311:235-42.
81. Bjorkander J, Bake B, Oxelius V, Hanson LA. Impaired lung function in patients with IgA deficiency and low levels of IgG2 or IgG3. N Engl J Med 1985;313:720-4.
82. Umetsu DT, Ambrosine DM, Quinti I, Siber GR, Geha RS. Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med 1985;313:1247-51.
83. Schoettler JJ, Schleissner LA, Heiner DC. Familial IgE deficiency associated with sinopulmonary disease. Chest 1989;96:516-21.
84. Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine 1985;64:145-56.
85. Cunningham-Rundles C, Siegal F, Smithwick E, et al. Efficacy of intravenous immuno-globulin in primary humoral immunodeficiency disease. Ann Int Med 1984;101:435-9.
86. Cunningham-Rundles C. Clinical and immunological analysis of 103 patients with common variable immunodeficiency. J Clin Immunol 1989;9:22-33.
87. Watts WJ, Watts MB, Dai W, Cassidy JT, Grum CM, Weg JG. Respiratory dysfunction in patients with common variable hypogammaglobulinemia. American Review of Respiratory Disease 1986;134:699-703.
88. Cazzadori A, Di Perri G, Todeschini G, Luzzati R, Boschiero L, Perona G, Concia E. Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients. Chest 1995;107:101-6.